- Home
- PCVX vs CELH Comparison
PCVX vs CELH Comparison
Compare PCVX & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | CELH |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 10.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PCVX | CELH |
|---|---|---|
| Price | $49.61 | $41.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 18 |
| Target Price | ★ $101.67 | $62.39 |
| AVG Volume (30 Days) | 1.4M | ★ 9.5M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $2,125,838,000.00 |
| Revenue This Year | N/A | $85.38 |
| Revenue Next Year | N/A | $31.08 |
| P/E Ratio | ★ N/A | $325.72 |
| Revenue Growth | N/A | ★ 55.07 |
| 52 Week Low | $27.66 | $21.10 |
| 52 Week High | $94.76 | $66.74 |
Technical Indicators
Market Signals| Indicator | PCVX | CELH |
|---|---|---|
| Relative Strength Index (RSI) | 65.33 | 33.80 |
| Support Level | $47.02 | $37.45 |
| Resistance Level | $50.27 | $41.86 |
| Average True Range (ATR) | 2.03 | 1.96 |
| MACD | 0.15 | 0.02 |
| Stochastic Oscillator | 93.32 | 38.11 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.